Super-Enhancers Dysregulations in Hematological Malignancies.
Super-Enhancers Dysregulations in Hematological Malignancies.
复制标题
血液恶性肿瘤中的超级增强子失调。
DOI:
10.3390/cells11020196
复制
发表时间:
2022-01-07
期刊:
影响因子:
6
通讯作者:
Lobry C
中科院分区:
文献类型:
--
作者:
Belloucif Y;Lobry C
Hematological malignancies affecting either the lymphoid or the myeloid lineages involve epigenetic mutations or dysregulation in the majority of cases. These epigenetic abnormalities can affect regulatory elements in the genome and, particularly, enhancers. Recently, large regulatory elements known as super-enhancers, initially identified for their critical roles in cell-type specific expression regulation of genes controlling cell identity, have been shown to also be involved in tumorigenesis in many cancer types and hematological malignancies via the regulation of numerous oncogenes, including MYC. In this review, we highlight the existing links between super-enhancers and hematological malignancies, with a particular focus on acute myeloid leukemia, a clonal hematopoietic neoplasm with dismal outcomes, resulting in an uncontrolled proliferation of myeloblasts, abnormally blocked during differentiation and accumulating within the patient’s bone marrow. We report recent works, performed during the last few years, treating this subject and consider the possibility of targeting oncogenic regulatory elements, as well as the effectiveness and limitations reported so far for such strategies.
登录
查看更多内容
影响因子:
37.3
作者:
Donati B;Lorenzini E;Ciarrocchi A
通讯作者:
Ciarrocchi A
影响因子:
158.5
作者:
Falini, B;Mecucci, C;Martelli, MF
通讯作者:
Martelli, MF
影响因子:
16
作者:
Calo, Eliezer;Wysocka, Joanna
通讯作者:
Wysocka, Joanna
影响因子:
11.4
作者:
通讯作者:
--
影响因子:
4
作者:
Barolo, Scott
通讯作者:
Barolo, Scott